HighTower Advisors
CL icon

HighTower Advisors’s Colgate-Palmolive CL Stock Holding History

HighTower Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,700
Closed -$1K – 2250
2019
Q4 		$1K Buy
+1,700
New +$116K ﹤0.01% 2261

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

HighTower Advisors's CL Position: Q1 2026 in Review

HighTower Advisors increased its Colgate-Palmolive (CL) stake by 5% in Q1 2026, buying an estimated $3.62M and bringing the position to 857,336 shares worth $73.1M. The position accounts for 0.08% of the portfolio, ranked #258.

HighTower Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • HighTower Advisors held 857,336 shares of Colgate-Palmolive worth $73.1M as of Q1 2026.
  • HighTower Advisors bought 40,604 Colgate-Palmolive shares in Q1 2026, an estimated $3.62M.
  • Colgate-Palmolive made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #258 holding.
  • HighTower Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Colgate-Palmolive position peaked at $101M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.